Home LiteratureArticle Details
PMID: 1680701 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Human CD4+CD45R0+ and CD4+CD45RA+ T cells synergize in response to alloantigens.

European journal of immunology ·Vol. 21 ·No. 10 ·1991-10-00 ·Pages 2517-22

Akbar AN, Salmon M, Ivory K, Taki S, Pilling D, Janossy G

Abstract

Alloantigens, unlike recall antigens, activate both CD45RA+ (naive) and CD45R0+ (memory) CD4+ cells to the same extent. These T cell subsets may therefore interact with each other in response to alloantigens on transplanted grafts. We have investigated if the ability of activated CD4+CD45RA+ and CD4+CD45R0+ T cells to produce and respond to interleukin 2 (IL2) and IL4 may be involved in this interaction. After activation, both subsets up-regulate their IL2 receptor (IL2R) and IL4R expression, yet IL4 substantially enhanced the proliferation of the CD4+CD45RA+ but not of the CD4+CD45R0+ T cell subset, while IL2 increased the proliferation of CD4+CD45R0+ but not of the CD4+CD45RA+ T cells. Significantly, the CD4+CD45RA+ T cells synthesized two- to threefold more mRNA for IL2 than the CD4+CD45R0+ subset, while the CD4+CD45R0+ T cells synthesized mRNA for IL4 and interferon-gamma exclusively. The addition of IL2 to alloactivated CD4+CD45R0+ T cells further up-regulated their production of all three lymphokine mRNA; in contrast, IL4 induced an increase in mRNA for IL2 in only the alloactivated CD4+CD45RA+ subset. The reciprocity in the ability of both these CD4+ T cells to synthesize and respond to IL2 and IL4 may provide a rationale for the regulation of lymphokine interactions in vivo. Furthermore, the synergy between these subsets in response to alloantigens, which was directly quantitated by co-culturing CD4+CD45RA+ and CD4+CD45R0+ cells together prior to activation, may potentiate the alloreactivity against transplanted grafts in vivo.

MeSH Terms
Antigens, CD/immunology CD4-Positive T-Lymphocytes/immunology Histocompatibility Antigens/immunology Humans Immunologic Memory In Vitro Techniques Interferon-gamma/biosynthesis,genetics Interleukin-2/biosynthesis,genetics,pharmacology Interleukin-4/biosynthesis,genetics,pharmacology Leukocyte Common Antigens Lymphocyte Activation RNA, Messenger/genetics Receptors, Interleukin-2/metabolism Receptors, Interleukin-4 Receptors, Mitogen/metabolism T-Lymphocyte Subsets/immunology
Chemicals
Antigens, CD Histocompatibility Antigens Interleukin-2 RNA, Messenger Receptors, Interleukin-2 Receptors, Interleukin-4 Receptors, Mitogen Interleukin-4 Interferon-gamma Leukocyte Common Antigens
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Akbar A N
Department of Clinical Immunology, Royal Free Hospital School of Medicine, London, GB.
Salmon M
Ivory K
Taki S
Pilling D
Janossy G
Article Info
Journal
European journal of immunology
Abbr.
Eur J Immunol
ISSN
0014-2980
Published
1991-10-00
Pages
2517-22
Language
English
Region
Germany
NLM ID
1273201
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com